Aclaris Therapeutics | DEFA14A: Others
Apr 25 07:05 ET
Aclaris Therapeutics | DEF 14A: Definitive information statements
Apr 25 07:05 ET
Aclaris Therapeutics | 8-K: Current report
Mar 19 16:33 ET
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Feb 27 07:20 ET
Aclaris Therapeutics | 8-K/A: Current report (Amendment)
Feb 5 16:36 ET
Aclaris Therapeutics | 8-K: Current report
Feb 5 16:35 ET
Aclaris Therapeutics | 8-K: Current report
Jan 19 00:00 ET
Aclaris Therapeutics | 8-K: Current report
Dec 19, 2023 16:15 ET
Aclaris Therapeutics | 8-K: Current report
Nov 13, 2023 07:42 ET
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
Nov 6, 2023 07:15 ET
Aclaris Therapeutics | 8-K: Current report
Sep 18, 2023 08:00 ET
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
Aug 7, 2023 07:15 ET
Aclaris Therapeutics | 8-K: Current report
Jun 12, 2023 16:15 ET
Aclaris Therapeutics | 8-K: Current report
Jun 2, 2023 16:05 ET
Aclaris Therapeutics | 8-K: Current report
Jun 1, 2023 16:18 ET
Aclaris Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
May 8, 2023 16:05 ET
Aclaris Therapeutics | 8-K: Aclaris Therapeutics Reports First Quarter 2023 Financial Results and Provides a Corporate Update
May 8, 2023 07:15 ET
Aclaris Therapeutics | DEFA14A: Others
Apr 20, 2023 07:03 ET
Aclaris Therapeutics | DEF 14A: Definitive proxy statements
Apr 20, 2023 07:01 ET
Aclaris Therapeutics | 8-K: Current report
Apr 14, 2023 07:11 ET
No Data
No Data